Forecasting Strategy Lead – Rare Disease Commercials

ANI Pharmaceuticals, Inc.; Princeton (NJ); Hybrid; USD 119,000 - 161,000; Full time

Job summary

ANI Pharmaceuticals, Inc. is seeking an Associate Director of Commercial Forecasting in Princeton, NJ (Hybrid).

The role focuses on developing and refining forecasts for in-line products within the Rare Disease portfolio, leveraging patient, prescriber, pharmacy, and distributor data to inform mid- and long-range planning. Responsibilities include owning forecasting models, collaborating with analytics and commercial teams, and presenting actionable insights to drive investment decisions.

Qualifications

• Bachelor’s degree in a related field; 7+ years of forecasting experience in a commercial stage pharma company.
• Ability to forecast complex products and refine forecasts over time, including products with multiple indications.

Responsibilities

• Own long-range forecasting models for ANI’s rare disease portfolio.
• Collaborate with Strategic Growth, Analytics, Market Access, Medical Affairs, and Finance to align forecasts with business objectives.
• Develop scenario planning and sensitivity analysis to support investment decisions and risk management.
• Translate assumptions into clear visualizations and presentations for internal and external stakeholders.
• Contribute to business development evaluations and strategic partnerships.

Skills

Forecasting

Analytical skills

Cross-functional collaboration

PowerPoint

Excel

Education

Bachelor’s degree in a related field

Tools

PowerPoint

Excel

Job description

ANI Pharmaceuticals, Inc. is seeking an Associate Director of Commercial Forecasting in Princeton, NJ (Hybrid).

The role focuses on developing and refining forecasts for in-line products within the Rare Disease portfolio, leveraging patient, prescriber, pharmacy, and distributor data to inform mid- and long-range planning. Responsibilities include owning forecasting models, collaborating with analytics and commercial teams, and presenting actionable insights to drive investment decisions.